Olmesartan Medoxomil
Product Images NDC 50090-3105

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 50090-3105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olmesartan Medoxomil Structural Formula (Image 01)

Olmesartan Medoxomil Structural Formula (Image 01)
Chemical structure of Olmesartan Medoxomil displaying its molecular arrangement with labeled functional groups and ring systems.*
FDA Label Image

Olmesartan Medoxomil Dose Response Placebo-adjusted Reduction In Blood Pressure (mmhg) (Image 02)

Olmesartan Medoxomil Dose Response Placebo-adjusted Reduction In Blood Pressure (mmhg) (Image 02)
A line graph depicting the reduction in blood pressure (BP) in mmHg as a function of Olmesartan Medoxomil dose in mg. The graph shows two lines comparing systolic and diastolic BP reductions, with systolic BP reductions represented by circles and diastolic BP reductions by triangles, both generally increasing with dose.*
FDA Label Image

Label Image (Lbl500903105)

Label Image (Lbl500903105)
Olmesartan Medoxomil Tablets 40 mg packaging label from A-S Medication Solutions. The label shows the NDC number 50090-3105 and indicates each film-coated tablet contains olmesartan medoxomil equivalent to 40 mg. The label instructs to store tablets at 68-77 degrees Fahrenheit. Package contains 30 tablets and includes manufacturer information for Teva Pharmaceuticals in Israel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.